Lipid A and liposomes containing lipid A as antigens and adjuvants - PubMed (original) (raw)
. 2008 Jun 6;26(24):3036-45.
doi: 10.1016/j.vaccine.2007.12.002. Epub 2007 Dec 26.
Affiliations
- PMID: 18226433
- DOI: 10.1016/j.vaccine.2007.12.002
Lipid A and liposomes containing lipid A as antigens and adjuvants
Carl R Alving et al. Vaccine. 2008.
Abstract
Lipid A derived from Gram-negative bacterial lipopolysaccharide is a potent adjuvant and antigen. Incorporation of lipid A into liposomes renders the liposomes themselves immunogenic, resulting in generation of specific antibodies that recognize either the individual liposomal lipids, or the unique pattern presented by the combination of lipids. Using liposomes containing lipid A, numerous polyclonal antisera and monoclonal antibodies have been produced against phospholipids, cholesterol, glycosphingolipids, and lipid A. Many of these antibodies have binding characteristics that are apparently similar to natural antibodies that are normally present in all human sera, and also antibodies that arise in response to various infections. Such antibodies probably represent a bridge between innate and adaptive immunity. The possible utility of liposomes containing lipid A as a constituent of certain types of novel vaccines was suggested by the observation that murine monoclonal antibodies to liposomal phosphatidylinositol-4-phosphate neutralized primary isolates of two different clades of HIV-1 in a human peripheral blood mononuclear cell neutralization assay.
Similar articles
- Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
Matyas GR, Wieczorek L, Beck Z, Ochsenbauer-Jambor C, Kappes JC, Michael NL, Polonis VR, Alving CR. Matyas GR, et al. AIDS. 2009 Oct 23;23(16):2069-77. doi: 10.1097/QAD.0b013e32832faea5. AIDS. 2009. PMID: 19710597 - Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.
Karasavvas N, Beck Z, Tong J, Matyas GR, Rao M, McCutchan FE, Michael NL, Alving CR. Karasavvas N, et al. Biochem Biophys Res Commun. 2008 Feb 22;366(4):982-7. doi: 10.1016/j.bbrc.2007.12.057. Epub 2007 Dec 26. Biochem Biophys Res Commun. 2008. PMID: 18088597 - Liposomes as vehicles for vaccines.
Alving CR, Banerji B, Shiba T, Kotani S, Clements JD, Richards RL. Alving CR, et al. Prog Clin Biol Res. 1980;47:339-55. Prog Clin Biol Res. 1980. PMID: 7208512 - Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants.
Alving CR. Alving CR. Immunobiology. 1993 Apr;187(3-5):430-46. doi: 10.1016/S0171-2985(11)80355-4. Immunobiology. 1993. PMID: 8330907 Review. - HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.
Alving CR, Beck Z, Karasavva N, Matyas GR, Rao M. Alving CR, et al. Mol Membr Biol. 2006 Nov-Dec;23(6):453-65. doi: 10.1080/09687860600935348. Mol Membr Biol. 2006. PMID: 17127618 Review.
Cited by
- Enhancing nicotine vaccine immunogenicity with liposomes.
Lockner JW, Ho SO, McCague KC, Chiang SM, Do TQ, Fujii G, Janda KD. Lockner JW, et al. Bioorg Med Chem Lett. 2013 Feb 15;23(4):975-8. doi: 10.1016/j.bmcl.2012.12.048. Epub 2012 Dec 27. Bioorg Med Chem Lett. 2013. PMID: 23313243 Free PMC article. - Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime-protein boost HIV-1 vaccine.
Pouliot K, Buglione-Corbett R, Marty-Roix R, Montminy-Paquette S, West K, Wang S, Lu S, Lien E. Pouliot K, et al. Vaccine. 2014 Sep 3;32(39):5049-56. doi: 10.1016/j.vaccine.2014.07.010. Epub 2014 Jul 18. Vaccine. 2014. PMID: 25045815 Free PMC article. - Licensed liposomal vaccines and adjuvants in the antigen delivery system.
Krasnopolsky Y, Pylypenko D. Krasnopolsky Y, et al. BioTechnologia (Pozn). 2022 Dec 24;103(4):409-423. doi: 10.5114/bta.2022.120709. eCollection 2022. BioTechnologia (Pozn). 2022. PMID: 36685697 Free PMC article. Review. - Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose.
de Titta A, Ballester M, Julier Z, Nembrini C, Jeanbart L, van der Vlies AJ, Swartz MA, Hubbell JA. de Titta A, et al. Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19902-7. doi: 10.1073/pnas.1313152110. Epub 2013 Nov 18. Proc Natl Acad Sci U S A. 2013. PMID: 24248387 Free PMC article. - Outer Membrane Vesicle Vaccines from Biosafe Surrogates Prevent Acute Lethal Glanders in Mice.
Norris MH, Khan MSR, Chirakul S, Schweizer HP, Tuanyok A. Norris MH, et al. Vaccines (Basel). 2018 Jan 10;6(1):5. doi: 10.3390/vaccines6010005. Vaccines (Basel). 2018. PMID: 29320408 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources